Global Diabetes Drugs Market 2011-2015

NEW YORK, Nov. 14, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Diabetes Drugs Market 2011-2015

http://www.reportlinker.com/p01027189/Global-Diabetes-Drugs-Market-2011-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

 

TechNavio's analysts forecast the Global Diabetes Drugs market to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Diabetes Drugs market has also been witnessing the trend of increasing awareness and education. However, the increasing use of complementary and alternative medicine (CAM) could pose a challenge to the growth of this market.

 

TechNavio's report, the Global Diabetes Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Diabetes Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

 

Key vendors dominating this space include Eli Lilly and Co., Merck and Co. Inc., Novo Nordisk A/S and Sanofi S.A.

 

Key questions answered in this report:

What will the market size be in 2015 and at what will be the growth rate?

What are key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by key vendors?

What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

 

TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

 

 

 

01. Executive Summary

02. Introduction

03. Market Coverage

Market Overview

Key Offerings

04. Market Landscape

04.1 Global Diabetes Drugs Market

Market Size

04.2 Available Drug Classes for Diabetes

04.3 Share of DPP4 Drugs in BRIC Countries in 2011

Brazil

India

Russia

China

Consolidated Share of DPP4 Drugs in BRIC Countries in 2011

04.4 Share of DPP4 Drugs in European Countries in 2011

France

Germany

Italy

Spain

UK

Consolidated Share of DPP4 Drugs in European Countries in 2011

04.5 Five Forces Analysis

05. Geographical Segmentation

06. Rate of Incidence and Prevalence

07. Vendor Landscape

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

14.1 Novo Nordisk A/S

Business Overview

SWOT Analysis

14.2 Merck and Co., Inc.

Business Overview

SWOT Analysis

14.3 Bristol-Myers Squibb Co.

Business Overview

SWOT Analysis

14.4 Sanofi S.A.

Business Overview

SWOT Analysis

15. Other Reports in this Series

 

List of Exhibits:

Exhibit 1: Global Diabetes Drugs Market 2011-2015 (US$ million)

Exhibit 2: Global Diabetes Drugs Market by Route of Administration

Exhibit 3: Global Diabetes Drugs Market by Geographical Segmentation 2011

Exhibit 4: Global Diabetes Drugs Market by Vendor Segmentation 2011

 

 

 

To order this report:

Drug_and_Medication Industry: Global Diabetes Drugs Market 2011-2015

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.